Genetically targeted radiotherapy of head and neck squamous cell carcinoma using the sodium-iodide symporter (NIS)

Head and Neck

Volumn 26, Issue 3, 2004, Pages 265-271

  Gaut, Andrew W ^a   Niu, Gang ^b   Krager, Kimberly J ^b   Graham, Michael M ^a   Trask, Douglas K ^a   Domann, Frederick E ^b  

^a UNIVERSITY OF IOWA   (United States)

^b B 180 Med Labs   (United States)

Author keywords

Gene therapy; Head and neck squamous cell carcinoma; NIS; Radioiodide; Sodium iodide symporter

Indexed keywords

IODINE 125; IODINE 131; SODIUM IODIDE SYMPORTER;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CANCER RADIOTHERAPY; CLONOGENIC ASSAY; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOIODINATION; RADIOISOTOPE DIAGNOSIS; RADIOISOTOPE DISTRIBUTION; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; VIRUS EXPRESSION;

ADENOVIRIDAE; ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; FEASIBILITY STUDIES; FEMALE; GENE THERAPY; HEAD AND NECK NEOPLASMS; IODINE RADIOISOTOPES; MICE; MICE, NUDE; SYMPORTERS;

EID: 1442325309     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/hed.10369     Document Type: Article

References (18)

1. Lamont JP, Kuhn JA, Nemunaitis JJ, McCarty TM. Gene therapy for head and neck cancers. Oncology (Huntingt) 2001;15:303-308; discussion 311-314.
2. Smanik PA, Liu Q, Furminger TL, et al. Cloning of the human sodium iodide symporter. Biochem Biophys Res Commun 1996;226:339-345.
3. Dai G, Levy O, Carrasco N. Cloning and characterization of the thyroid iodide transporter. Nature 1996;379:458-460.
4. Eskandari S, Loo DD, Dai G, Levy O, Wright EM, Carrasco N. Thyroid Na+/I- symporter. Mechanism, stoichiometry, and specificity. J Biol Chem 1997;272:27230-27238.
5. Kotzerke J, Fenchel S, Guhlmann A, et al. Pharmacokinetics of 99Tcm-pertechnetate and 188Re-perrhenate after oral administration of perchlorate: option for subsequent care after the use of liquid 188Re in a balloon catheter. Nucl Med Commun 1998;19:795-801.
6. Lin WY, Hsieh JF, Tsai SC, Yen TC, Wang SJ, Knapp FF Jr. A comprehensive study on the blockage of thyroid and gastric uptakes of 188Re-perrhenate in endovascular irradiation using liquid-filled balloon to prevent restenosis. Nucl Med Biol 2000;27:83-87.
7. Larsen RH, Slade S, Zalutsky MR. Blocking [211At] astatide accumulation in normal tissues: preliminary evaluation of seven potential compounds. Nucl Med Biol 1998;25:351-357.
8. Van Sande J, Massart C, Beauwens R, et al. Anion selectivity by the sodium iodide symporter. Endocrinology 2003;144:247-252.
9. Mandell RB, Mandell LZ, Link CJ Jr. Radioisotope concentrator gene therapy using the sodium/iodide symporter gene. Cancer Res 1999;59:661-668.
10. Nakamoto Y, Saga T, Misaki T, et al. Establishment and characterization of a breast cancer cell line expressing Na+/I- symporters for radioiodide concentrator gene therapy. J Nucl Med 2000;41:1898-1904.
11. Huang M, Batra RK, Kogai T, et al. Ectopic expression of the thyroperoxidase gene augments radioiodide uptake and retention mediated by the sodium iodide symporter in non-small cell lung cancer. Cancer Gene Ther 2001;8:612-618.
12. Cho JY, Shen DH, Yang W, et al. In vivo imaging and radioiodine therapy following sodium iodide symporter gene transfer in animal model of intracerebral gliomas. Gene Ther 2002;9:1139-1145.
13. Groot-Wassink T, Aboagye EO, Glaser M, Lemoine NR, Vassaux G. Adenovirus biodistribution and noninvasive imaging of gene expression in vivo by positron emission tomography using human sodium/iodide symporter as reporter gene. Hum Gene Ther 2002;13:1723-1735.
14. Spitzweg C, Dietz AB, O'Connor MK, et al. In vivo sodium iodide symporter gene therapy of prostate cancer. Gene Ther 2001;8:1524-1531.
15. Li D, Duan L, Freimuth P, O'Malley BW Jr. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer. Clin Cancer Res 1999;5:4175-4181.
16. Min JJ, Chung JK, Lee YJ, et al. In vitro and in vivo characteristics of a human colon cancer cell line, SNU-C5N, expressing sodium-iodide symporter. Nucl Med Biol 2002;29:537-545.
17. Carlin S, Cunningham SH, Boyd M, McCluskey AG, Mairs RJ. Experimental targeted radioiodide therapy following transfection of the sodium iodide symporter gene: effect on clonogenicity in both two-and three-dimensional models. Cancer Gene Ther 2000;7:1529-1536.
18. Boland A, Ricard M, Opolon P, et al. Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy. Cancer Res 2000;60:3484-3492.